STOCK TITAN

Ensign Group Inc SEC Filings

ENSG NASDAQ

Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.

Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.

Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.

By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.

Rhea-AI Summary

Ensign Group director Barry M. Smith reported a planned sale of company stock. On February 2, 2026, he sold 700 shares of common stock at $171.54 per share in an open-market transaction. The trade was made under a Rule 10b5-1 trading plan adopted on July 29, 2025, indicating it was pre-arranged. After this sale, he beneficially owns 23,552 shares of Ensign Group common stock directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.85%
Tags
insider
-
Rhea-AI Summary

The Ensign Group, Inc. filed a current report to note that it issued a press release with its financial results for the fourth quarter and year ended December 31, 2025. The press release is furnished as Exhibit 99.1.

The company highlights several non-GAAP measures used in that release, including Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations for its real estate segment. The filing explains how each metric is calculated from net income and why management believes these measures provide supplemental insight, while emphasizing they should be considered alongside GAAP results and may not be comparable to similar measures used by other companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.85%
Tags
current report
-
Rhea-AI Summary

The Ensign Group, Inc. is a holding company that provides skilled nursing, senior living, rehabilitation and ancillary services through independent subsidiaries in 17 states. As of December 31, 2025, it operated 373 skilled nursing and senior living facilities with 37,911 operational skilled nursing beds and 3,402 senior living units.

About 95.6% of 2025 revenue came from skilled nursing facilities, with the remainder from real estate, senior living and ancillary services. Ensign also owns 158 healthcare properties and operates a captive REIT, Standard Bearer, which holds 152 properties and generated $126.9 million of rental revenue in 2025.

Medicaid and Medicare are the largest payors, representing 46.6% and 24.7% of 2025 skilled services revenue. The company has grown through acquisitions, adding 145 facilities since 2021, and focuses on high‑acuity patients, local leadership, and value‑based care. The filing details extensive regulatory and reimbursement risks across Medicare, Medicaid and emerging value‑based payment models.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.85%
Tags
annual report
Rhea-AI Summary

Barry M. Smith has filed a notice under Rule 144 to sell 700 shares of common stock through Fidelity Brokerage Services LLC on or about 02/02/2026 on the NASDAQ, with an aggregate market value of $120,078.00. The issuer had 57,924,783 shares of this class outstanding.

The shares to be sold were acquired through restricted stock vesting compensation transactions between 01/15/2024 and 01/17/2025. Over the prior three months, Smith sold 700 shares of common stock on each of three dates, with gross proceeds of $126,448.00, $128,989.00, and $121,513.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
other
-
Rhea-AI Summary

Ensign Group director John O. Agwunobi reported small, pre-planned stock sales. On January 20, 2026, he sold 246 shares of Ensign Group common stock at an average price of $179.82 per share. On January 21, 2026, he sold an additional 146 shares at an average price of $178.31 per share, for a total of 392 shares sold.

After these transactions, he beneficially owned 9,087.149 Ensign Group shares in direct form. The filing states these sales were executed under a Rule 10b5-1 trading plan adopted on July 31, 2025, which is a pre-arranged program allowing insiders to sell shares according to preset instructions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ENSG filed a Form 144 notice for a planned sale of 146 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of 26033.26. These shares are part of a class with 57924783 shares outstanding and are expected to be sold around 01/21/2026. The securities were acquired on 01/17/2026 via restricted stock vesting from the issuer as compensation.

The person named in the recent sale history, John Agwunobi, previously sold 246 common shares on 11/06/2025 for gross proceeds of 46462.02 and another 246 shares on 01/20/2026 for gross proceeds of 44235.72. This notice also confirms the seller represents they are not aware of undisclosed material adverse information about the issuer’s operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Ensign Group, Inc. director and CFO Suzanne Snapper filed an amended Form 4 to correct how a prior stock gift was reported. A November 7, 2025 gift of 2,675 shares of common stock had previously been shown as coming from her direct holdings. This amendment clarifies that the gifted shares were held indirectly through a trust rather than directly.

Following the corrected reporting, Snapper is shown as owning 269,204 shares of Ensign Group common stock directly and 56,340 shares indirectly, held by the Eric and Suzanne Snapper Family Trust, of which she and her spouse are trustees. The transaction was a gift reported at a price of $0 per share and does not reflect a market sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ensign Group, Inc. director Barry M. Smith reported an equity award of 600 shares of common stock on January 15, 2026, at a grant price of $0 per share. After this award, he beneficially owns 24,252 shares of Ensign Group common stock directly. The 600 granted shares are subject to vesting in three equal annual installments beginning on January 15, 2027, meaning they become fully his over a three-year period if vesting conditions are met.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The Ensign Group director reports a new stock grant. Director Daren Shaw received an award of 600 shares of Ensign Group common stock on January 15, 2026 at a price of $0 per share. Following this award, he beneficially owns 24,726 common shares directly.

The grant is subject to a multi-year vesting schedule. The 600 shares vest in three equal annual installments beginning January 15, 2027, meaning one-third of the award becomes fully owned each year over three years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

The Ensign Group director reports a new stock award. Director Ann Scott Blouin acquired 600 shares of Ensign Group common stock on January 15, 2026 in a transaction reported at a price of $0 per share, indicating a share grant rather than a market purchase. After this award, she beneficially owns 23,227 Ensign Group shares in direct ownership.

The filing notes that these 600 shares vest in three equal annual installments beginning January 15, 2027, so the director will earn the shares over time rather than receiving them all at once.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Ensign Group (ENSG) SEC filings are available on StockTitan?

StockTitan tracks 99 SEC filings for Ensign Group (ENSG), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Ensign Group (ENSG)?

The most recent SEC filing for Ensign Group (ENSG) was filed on February 4, 2026.